VIDEO: New Frontiers in Hormone Therapy for Breast Cancer

Hormone therapy is a standard treatment for both early-stage and metastatic breast cancer. New studies show that extending the duration of treatment in post-menopausal women beyond the standard five years may reduce cancer recurrence and improve survival.

In this video, Dr. Hope Rugo discusses a promising new class of hormone treatments -- Aromatase inhibitors -- and how they may benefit patients when used either alone or in combination with the widely used breast cancer drug Tamoxifen.

Interviewee:

Hope S. Rugo, MD, Clinical Professor of Medicine; Director, Breast Oncology Clinical Trials Program, UCSF Helen Diller Family Comprehensive Cancer Center

This Video was originally published on Beet.TV.